4.6 Article

ROR1-AS1 might promote in vivo and in vitro proliferation and invasion of cholangiocarcinoma cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion

Xian-Long Meng et al.

Summary: This study reveals the genomic features and the immune suppressive metastasis-prone niche of intrahepatic cholangiocarcinoma (ICC) with perineural invasion (PNI). Patients with PNI have a poor prognosis after surgery but show a good response to adjuvant chemotherapy.

HEPATOLOGY INTERNATIONAL (2023)

Article Oncology

Characteristic of Perineural Invasion in Hilar Cholangiocarcinoma Based on Whole-Mount Histologic Large Sections of Liver

Si-Yuan Wang et al.

Summary: This study developed a whole-mount histologic large sections (WHLS) method of the liver for evaluating peripheral nerve invasion (PNI) in hilar cholangiocarcinoma (HCCA). The study found that extrahepatic PNI is prevalent, while intrahepatic nerve invasion is rare. Additionally, moderately and poorly differentiated tumors are more prone to PNI.

FRONTIERS IN ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

ROR1-AS1 knockdown inhibits growth and invasion and promotes apoptosis in NSCLC cells by suppression of the PI3K/Akt/mTOR pathway

Fengbo Li et al.

Summary: The study revealed that ROR1-AS1 is upregulated in NSCLC and knocking down ROR1-AS1 can inhibit the invasive ability and growth of NSCLC cells, inducing apoptosis by suppressing the activation of the PI3K/Akt/mTOR pathway.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)

Review Oncology

Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies

Yuming Zhao et al.

Summary: ROR1, a receptor tyrosine kinase, is crucial in embryogenesis and overexpressed in malignant tumors, with potential as a target for cancer therapy. Antibody-based immunotherapies show promising outcomes, while small molecule inhibitors are underappreciated. Further research is needed to understand ROR1's tyrosine kinase function and develop effective therapeutic strategies.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

lncRNA ROR Promotes Gastric Cancer Drug Resistance

Shuai Wang et al.

CANCER CONTROL (2020)

Article Biochemistry & Molecular Biology

TIMER2.0 for analysis of tumor-infiltrating immune cells

Taiwen Li et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Biochemistry & Molecular Biology

Linc-ROR promotes arsenite-transformed keratinocyte proliferation by inhibiting P53 activity

Xinyang Li et al.

METALLOMICS (2020)

Review Oncology

Molecular Pathogenesis of Cholangiocarcinoma

Peter L. Labib et al.

BMC CANCER (2019)

Review Pharmacology & Pharmacy

Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells

Amin Kamrani et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2019)

Article Medicine, Research & Experimental

ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models

Lars Wallstabe et al.

JCI INSIGHT (2019)

Article Oncology

Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues

Ashwini Balakrishnan et al.

CLINICAL CANCER RESEARCH (2017)

Review Pharmacology & Pharmacy

Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy

Mahdi Shabani et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2015)

Review Oncology

The receptor tyrosine kinase ROR1-An oncofetal antigen for targeted cancer therapy

Mohammad Hojjat-Farsangi et al.

SEMINARS IN CANCER BIOLOGY (2014)

Review Gastroenterology & Hepatology

Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma

Sumera Rizvi et al.

GASTROENTEROLOGY (2013)